You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

USE OF ANTIPLATELET AGENTS FOR THE PREVENTION OF FIRST AND RECURRENT STROKE

Gorelick, Philip B.

CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000293701.92969.62
Article
Abstract

Antiplatelet agents are an important component of the neurologist's armamentarium for stroke prevention. This chapter reviews major antiplatelet agents that are approved by the US Food and Drug Administration for stroke prevention. The discussion focuses primarily on the efficacy, safety, and cost of the following agents in recurrent stroke prevention: aspirin, aspirin plus extended-release dipyridamole, clopidogrel, and ticlopidine. The use of aspirin in prevention of a first stroke will also be discussed as will the concepts of aspirin "resistance" and "failure."

© 2005 American Academy of Neurology